Drugs / Nisha-Amalaki
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06487598 Comparator | Jul 2024 → Jul 2025 overdue | type 1 diabetes mellitus | Hirabai Cowasji Jehangir Medical Research Institute | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nisha-Amalaki | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06487598 ↗ |
| Route | Oral | “Tab Nisha-Amalaki 500 mg twice a day” NCT06487598 ↗ |